PLRX FY 2023 Earnings — Pliant Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

PLRXPliant Therapeutics, Inc.

$85M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-83.7% YoY

Gross Profit

$2M100.0% margin

Operating Income

-$184M-11654.7% margin

Net Income

-$161M-10211.1% margin

EPS (Diluted)

$-2.75

Cash Flow

Operating Cash Flow

-$116M

Free Cash Flow

-$117M

Stock-Based Comp.

$44M

Balance Sheet

Total Assets

$512M

Total Liabilities

$39M

Stockholders' Equity

$474M

Cash & Equivalents

$63M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$10M	-83.7%
Gross Profit	$2M	$10M	-83.7%
Operating Income	-$184M	-$127M	-44.8%
Net Income	-$161M	-$123M	-30.8%